Association of the VEGF-1154G/A polymorphism with recurrent implantation failure in infertile Iranian women
Archives of Advances in Biosciences,
Vol. 15 No. 1 (2024),
24 January 2024
,
Page 1-6
https://doi.org/10.22037/aab.v15i1.47224
Abstract
Introduction: Most IVF embryos fail to implant before clinical diagnosis. Successful implantation of an embryo relies on the endometrium forming a connection with the embryo, thereby enabling blood vessel formation and a suitable environment for the embryo to develop. Vascular Endothelial Growth Factor (VEGF) plays a vital role in angiogenesis. The role of VEGF polymorphisms, including VEGF1154 G/A (rs1570360), has been shown in recurrent implantation failure (RIF) in various ethnic groups.
Materials and Methods: For this research, 148 healthy women with a previous successful pregnancy served as the control group, while the case group consisted of 75 women with Recurrent Implantation Failure (RIF) who had not achieved a pregnancy after transferring 10 embryos during three or more IVF cycles. Genomic DNA was extracted from peripheral blood cells. PCR was performed, and amplified DNA fragments were sequenced using the Sanger method.
Results: After analyzing with SHEsis application, while the control group exhibited Hardy- Weinberg equilibrium (HWE), a deviation was observed in the case group. However, the chi- square test did not reveal a statistically significant difference between the groups.
Conclusion: There was no significant association between this SNP and RIF in our case-control study. The presence of Hardy-Weinberg disequilibrium in the case group, despite the lack of significant difference from the control group, warrants further exploration of potential contributing factors and their implications for the study of this locus in relation to recurrent implantation failure.
- Recurrent implantation failure
- Endometrium
- VEGF 1154G A polymorphism
How to Cite
References
Vempati P, Popel AS, Mac Gabhann F. Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning. Cytokine & growth factor reviews. 2014 Feb 1;25(1):1-9.[DOI: 10.1016/j.cytogfr.2013.11.002]
Torry D.S., Leavenworth J., Chang M., Maheshwari V., Groesch K., Ball E.R and Torrey R.J. Angiogenesis in implantation. DOI: 10.1007/s10815-007-9152-7/J Assist Reprod Genet/2007 Jul;24(7):303-15..[PMID]
Shim SH, Kim JO, Jeon YJ, An HJ, Lee HA, Kim JH, Ahn EH, Lee WS, Kim NK. Association between vascular endothelial growth factor promoter polymorphisms and the risk of recurrent implantation failure. Experimental and Therapeutic Medicine. 2018 Feb;15(2):2109-19.[DOI:10.3892/etm.2017.5641] [PMID]
Mrozikiewicz AE, Kurzawińska G, Ożarowski M, Walczak M, Ożegowska K, Jędrzejczak P. Polymorphic variants of genes encoding angiogenesis-related factors in infertile women with recurrent implantation failure. International Journal of Molecular Sciences. 2023 Feb 21;24(5):4267.[DOI: 10.3390/ijms24054267]
Muter J., Lynch V.J., McCoy R.C and Brosens J.J. Human embryo implantation. Doi: 10.1242/dev.201507/Human development , Reproductive biology. (2023) 150 (10): dev201507.[DOI:10.1242/dev.201507]
Wilcox AJ, Baird DD, Weinberg CR. Time of implantation of the conceptus and loss of pregnancy. New England Journal of Medicine. 1999 Jun 10;340(23):1796-9.
[DOI:10.1056/nejm199906103402304]
Lee HH, Hong SH, Shin SJ, Ko JJ, Oh D, Kim NK. Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion. Fertility and sterility. 2010 Mar 1;93(4):1244-7.
[DOI:10.1016/j.fertnstert.2008.11.017]
Busnelli A, Somigliana E, Cirillo F, Baggiani A, Levi-Setti PE. Efficacy of therapies and interventions for repeated embryo implantation failure: a systematic review and meta-analysis. Scientific Reports. 2021 Jan 18;11(1):1747. [DOI: 10.1038/s41598-021-81439-6]
Ferrara N, Frantz G, LeCouter J, Dillard-Telm L, Pham T, Draksharapu A, Giordano T, Peale F. Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. The American journal of pathology. 2003 Jun 1;162(6):1881-93. [DOI: 10.1016/s0002-9440(10)64322-2]
Vagnini L.D., Nascimento A.M., Canas M.do C T., Renzi A., Oliveira-pelegrin G R., Petersen C G., Mauri A L., Oliveira J B A., Baruffi R L.R., Cavagna M and Franco Jr J G. The relationship between Vascular Endothelial Growth Factor 1154G/A Polymorphism and Recurrent Implantation Failure. DOI: 10.1159/000437370/Medical Principles and practice August 21, 2015; 24 (6): 533–537.[DOI:10.1159/000437370]
Bashiri A, Halper KI, Orvieto R. Recurrent Implantation Failure-update overview on etiology, diagnosis, treatment and future directions. Reproductive Biology and Endocrinology. 2018 Dec 5;16(1):121.
[DOI: 10.1186/s12958-018-0414-2]
Vidyadhari M, Sujatha M, Krupa P, Nallari P, Venkateshwari A. Association of genetic polymorphism of vascular endothelial growth factor in the etiology of recurrent pregnancy loss: a triad study. Journal of assisted reproduction and genetics. 2019 May 15;36:979-88. [DOI: 10.1007/s10815-019-01431-y]
Guo X, Yi H, Li TC, Wang Y, Wang H, Chen X. Role of vascular endothelial growth factor (VEGF) in human embryo implantation: clinical implications. Biomolecules. 2021 Feb 10;11(2):253. [DOI: 10.3390/biom11020253]
Harrity C, Shkrobot L, Walsh D, Marron K. ART implantation failure and miscarriage in patients with elevated intracellular cytokine ratios: response to immune support therapy. Fertility Research and Practice. 2018 Dec;4:1-9.[DOI: 10.1186/s40738-018-0052-6]
Amin I., Pandith A., Manzoor U., Dil Afroze S M., Koul A., Wani S., Ahmad A., Qasim I., Rashid M., Wani U., Anwar I., Aein Q.u and Mansoor S. The Implications of Placental Networking and Vascular Remodeling VEGF Gene Sequence Variations and its expression as a Vital Factor to Contribute in Etiopathogenesis of Recurrent Pregnancy Loss.
[DOI:10.1016/j.rbmo.2021.08.009]
- Abstract Viewed: 119 times
- pdf Downloaded: 54 times